UAE Oncology Based Molecular Diagnostics Market Size & Outlook
UAE oncology based molecular diagnostics market, 2018-2030 (US$M)
Related Markets
UAE oncology based molecular diagnostics market highlights
- The UAE oncology based molecular diagnostics market generated a revenue of USD 23.2 million in 2024 and is expected to reach USD 34.6 million by 2030.
- The UAE market is expected to grow at a CAGR of 6.6% from 2025 to 2030.
- In terms of segment, breast cancer was the largest revenue generating type in 2024.
- Breast Cancer is the most lucrative type segment registering the fastest growth during the forecast period.
Oncology based molecular diagnostics market data book summary
| Market revenue in 2024 | USD 23.2 million |
| Market revenue in 2030 | USD 34.6 million |
| Growth rate | 6.6% (CAGR from 2025 to 2030) |
| Largest segment | Breast cancer |
| Fastest growing segment | Breast Cancer |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Kidney Cancer |
| Key market players worldwide | Abbott Laboratories, Bayer AG, Agilent Technologies Inc, Danaher Corp, Hologic Inc, Qiagen NV, Siemens AG, Sysmex Corp, Becton Dickinson & Co, Roche Holding AG ADR |
Other key industry trends
- In terms of revenue, UAE accounted for 0.6% of the global oncology based molecular diagnostics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa oncology based molecular diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 34.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Oncology based Molecular Diagnostics Market Scope
Oncology based Molecular Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UAE oncology based molecular diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oncology based molecular diagnostics market will help companies and investors design strategic landscapes.
Breast cancer was the largest segment with a revenue share of 21.12% in 2024. Horizon Databook has segmented the UAE oncology based molecular diagnostics market based on breast cancer, prostate cancer, colorectal cancer, cervical cancer, liver cancer, lung cancer, blood cancer, kidney cancer covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to UAE oncology based molecular diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UAE oncology based molecular diagnostics market databook
-
Our clientele includes a mix of oncology based molecular diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE oncology based molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into UAE oncology based molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UAE oncology based molecular diagnostics market size, by type, 2018-2030 (US$M)
UAE Oncology based Molecular Diagnostics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
